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Introduction: In serum, 25-hydroxy-vitamin D (25(OH)D) can be found in two forms, namely 25(OH)D2 and 25(OH)D3. We recently published a 
mathematical method to estimate the 25(OH)D2 recovery without spiking the samples. Since then, new “total” vitamin D immunoassays have 
appeared on the market (Roche “Total” vitamin D, Siemens Centaur vitamin D “total”, “total” vitamin D on DiaSorin Liaison XL, Abbott Architect 
Vitamin D). We aimed to study the 25(OH)D2 recovery of these new immunoassays and re-evaluate the  cross-reactivity of previously studied assays 
(IDS iSYS Vitamin D and DiaSorin RIA).
Materials and Methods: We only used native samples. First, in a group of 19 individuals presenting 25(OH)D3 levels exclusively and ranging 
from 6 to 90 ng/mL, approximately, we defined the regression equation of each immunoassay method in comparison with the Perkin-Elmer 
LCMS/MS method run on a AbSciex TQ 5500 instrument. Then, we established the respective concentration of 25(OH)D3 and 25(OH)D2 in the 
serum of 11 individuals supplemented with various levels of vitamin D2. For each method, with the help of the regression equation previously 
obtained, we calculated what would be the “immunoassay-equivalent” of 25(OH)D3 based on the LCMS/MS 25(OH)D3 value. We thus subtracted 
this amount to the “total” value obtained with the respective immunoassay to obtain the 25(OH)D2 “immunoassay-equivalent” concentration. Finally, 
we divided this amount by the 25(OH)D2 obtained with the LCMS/MS to calculate the recovery.
Conclusion: As we previously shown, IDS Isys and Diasorin RIA, present a 100% cross-reactivity with 25(OH)D2. Among the new 
“total” immunoassay, Roche Elecsys is the only one to present a 100% cross-reactivity. The DiaSorin Liaison XL presents a slight but 
significant positive bias whereas Centaur and Architect are respectively clearly over and underestimating 25(OH)D2 when compared
with the Perkin-Elmer LCMS/MS.
Results:
Regression Equation 
obtained in Individuals 
with 25(OH)D3 only 
(PED3=25(OH)D3 
obtained with the 
LCMSMS)  
Mean cross-reactivity (%) 
for 25(OH)D2 (95% CI)
1.27 x PED3 - 6.9 61.6 (54.3 - 69.0)
1.02 x PED3 - 0.57 101(100.6 - 101.6)
0.82 x PED3 + 3.75 98 (94.2-102)
0.93 x PED3 - 1.69 113 (108-118)
0.80 x PED3 + 3.41 101 (97-106)








The table  show the different regression 
equation and the cross reactivity (95%CI) 
obtained with the different immunoassays 
compared LCMSMS considered (arbitrarily) had 
100 % cross-reactivity for both D2 and D3.
